Correction to: Scientific Reports https://doi.org/10.1038/srep09925, published online 20 April 2015
The Article contains an error in Figure 2, where incorrect images were used during the image assembly.
The correct Figure 2 and accompanying legend appear below.
EGFR inhibitor was effective for triple WT MM cells. (A) Gefinitib (5 μM) exhibited moderate inhibition in NRAS WT myeloma cells but not in mutated cells; (B) Mutated NRAS was able to activate downstream effectors without EGFR signalling; (C) metabolic shift of NRAS WT myeloma cells (LP-1) treated or untreated with Gefitinib (5 μM) for 24 h. Heatmap showing top changed metabolites between groups (each column representing a replicate within group, n = 4). (D) MSEA showing significant change in metabolites within pentose phosphate pathway with (E) representative metabolite levels in LP-1 cells.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, Y., Huang, R., Ding, J. et al. Author Correction: Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway. Sci Rep 13, 21130 (2023). https://doi.org/10.1038/s41598-023-47497-8
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-023-47497-8
